Literature DB >> 18536914

Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.

J Stauss1, C Franzius, T Pfluger, K U Juergens, L Biassoni, J Begent, R Kluge, H Amthauer, T Voelker, L Højgaard, S Barrington, S Hain, T Lynch, K Hahn.   

Abstract

OBJECTIVE: The purpose of these guidelines is to offer to the nuclear medicine team a framework that could prove helpful in daily practice. These guidelines contain information related to the indications, acquisition, processing and interpretation of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) in paediatric oncology. The Oncology Committee of the European Association of Nuclear Medicine (EANM) has published excellent procedure guidelines on tumour imaging with (18)F-FDG PET (Bombardieri et al., Eur J Nucl Med Mol Imaging 30:BP115-24, 2003). These guidelines, published by the EANM Paediatric Committee, do not intend to compete with the existing guidelines, but rather aim at providing additional information on issues particularly relevant to PET imaging of children with cancer.
CONCLUSION: The guidelines summarize the views of the Paediatric Committee of the European Association of Nuclear Medicine. They should be taken in the context of "good practice" of nuclear medicine and of any national rules, which may apply to nuclear medicine examinations. The recommendations of these guidelines cannot be applied to all patients in all practice settings. The guidelines should not be deemed inclusive of all proper procedures or exclusive of other procedures reasonably directed to obtaining the same results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536914     DOI: 10.1007/s00259-008-0826-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  43 in total

1.  FDG-PET: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

2.  PET/CT with diagnostic CT in the evaluation of childhood sarcoma.

Authors:  Christiane Franzius; Kai U Juergens; Josef Vormoor
Journal:  AJR Am J Roentgenol       Date:  2006-02       Impact factor: 3.959

3.  Paediatric doses--a critical appraisal of the EANM paediatric dosage card.

Authors:  Søren Holm; Lise Borgwardt; Annika Loft; Jesper Graff; Ian Law; Liselotte Højgaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

Review 4.  18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's.

Authors:  Sue C Kaste; Scott C Howard; Elizabeth B McCarville; Matthew J Krasin; Philip G Kogos; Melissa M Hudson
Journal:  Pediatr Radiol       Date:  2004-11-16

Review 5.  PET/CT in the evaluation of childhood sarcomas.

Authors:  M Beth McCarville; Ryan Christie; Najat C Daw; Sheri L Spunt; Sue C Kaste
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 6.  PET applications in pediatrics.

Authors:  B L Shulkin
Journal:  Q J Nucl Med       Date:  1997-12

7.  Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?

Authors:  K U Juergens; M Weckesser; L Stegger; C Franzius; M Beetz; O Schober; W Heindel; D Wormanns
Journal:  Eur Radiol       Date:  2006-02-01       Impact factor: 5.315

Review 8.  Assessment of therapy response by FDG PET in pediatric patients.

Authors:  C Franzius; O Schober
Journal:  Q J Nucl Med       Date:  2003-03

9.  Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.

Authors:  J D Lucas; M J O'Doherty; J C Wong; J B Bingham; P H McKee; C D Fletcher; M A Smith
Journal:  J Bone Joint Surg Br       Date:  1998-05

10.  Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Authors:  B L Shulkin; R J Hutchinson; V P Castle; G A Yanik; B Shapiro; J C Sisson
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

View more
  45 in total

1.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

Review 2.  Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here: Summary Report of the 4th International Workshop on PET/MR Imaging; February 23-27, 2015, Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; H Barthel; A J Beer; J Bremerich; J Czernin; A Drzezga; C Franzius; V Goh; M Hartenbach; H Iida; A Kjaer; C la Fougère; C N Ladefoged; I Law; K Nikolaou; H H Quick; O Sabri; J Schäfer; M Schäfers; H F Wehrl; T Beyer
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

3.  Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.

Authors:  A Raciborska; K Bilska; K Drabko; E Michalak; R Chaber; M Pogorzała; K Połczyńska; G Sobol; M Wieczorek; K Muszyńska-Rosłan; M Rychlowska-Pruszyńska; C Rodriguez-Galindo; M Dziuk
Journal:  Clin Transl Oncol       Date:  2015-08-07       Impact factor: 3.405

Review 4.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

Review 5.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

6.  Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT.

Authors:  Yu-Mo Zhao; Ying-He Li; Tao Chen; Wei-Guang Zhang; Lin-Hao Wang; Jiatai Feng; Chenwei Li; Xu Zhang; Wei Fan; Ying-Ying Hu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

7.  Quantitative analysis of image metrics for reduced and standard dose pediatric 18F-FDG PET/MRI examinations.

Authors:  Pietro Zucchetta; Marco Branchini; Alessandra Zorz; Valentina Bodanza; Diego Cecchin; Marta Paiusco; Franco Bui
Journal:  Br J Radiol       Date:  2019-01-23       Impact factor: 3.039

8.  Pediatric nuclear medicine and pediatric radiology: modalities, image quality, dosimetry and correlative imaging: new strategies.

Authors:  Isabel Roca-Bielsa; Marina Vlajković
Journal:  Pediatr Radiol       Date:  2013-03-24

9.  Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.

Authors:  Sergios Gatidis; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Nina F Schwenzer; Jürgen F Schäfer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-26       Impact factor: 9.236

10.  Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.

Authors:  Michal Weiler-Sagie; Olga Kagna; Eldad J Dann; Ayelet Ben-Barak; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.